RankingsPricing
  1. JP-listed companies
  2. SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
  3. Financials
  4. Provision for income taxes

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.JP:2395

Market cap
¥78.5B
P/E ratio
22.1x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndProvision for income taxes (Million JPY)YoY (%)
Mar 31, 20251,149-21.16%
Mar 31, 20241,457-14.76%
Mar 31, 20231,709+68.17%
Mar 31, 20221,016+104.14%
Mar 31, 2021498+20.08%
Mar 31, 2020415-234.55%
Mar 31, 2019-308-115.30%
Mar 31, 20182,013+1475.53%
Mar 31, 2017128-85.86%
Mar 31, 2016903-8.97%
Mar 31, 2015992

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)